Len Rozamus

Len Rozamus is Senior Vice President, Technical Operations at Theseus Pharmaceuticals. An organic chemist with more than three decades of pharmaceutical discovery and development experience, Len began his career in medicinal chemistry at SmithKline Beecham and later transitioned to process development and the management of outsourced contract manufacturing for clinical programs at ARIAD Pharmaceuticals. As Sr. Director, Manufacturing Operations at ARIAD, Len provided leadership in every aspect of CMC, from pre-clinical programs through commercial products, primarily in support of ARIAD’s fast-track and breakthrough medications, including ICLUSIG® (ponatinib), approved for patients with treatment-resistant Ph+ leukemias; ALUNBRIG® (brigatinib), approved for ALK+ non-small cell lung cancer (NSCLC); EXKIVITY® (mobocertinib), approved for EGFR Exon 20 insertion+ NSCLC. Most recently, Len served as the Founder and President of Rozamus and Associates, Inc., leading a team of seasoned consultants providing strategic and operational guidance to small and large companies for product life-cycle management. Len holds a Master’s in Organic Chemistry from the University of Virginia and a B.S. in Chemistry from The College of William and Mary in Virginia.